IL138562A0 - Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses - Google Patents

Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses

Info

Publication number
IL138562A0
IL138562A0 IL13856299A IL13856299A IL138562A0 IL 138562 A0 IL138562 A0 IL 138562A0 IL 13856299 A IL13856299 A IL 13856299A IL 13856299 A IL13856299 A IL 13856299A IL 138562 A0 IL138562 A0 IL 138562A0
Authority
IL
Israel
Prior art keywords
collagen
native collagen
sterilising
liquid medium
compositions containing
Prior art date
Application number
IL13856299A
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of IL138562A0 publication Critical patent/IL138562A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)

Abstract

The invention concerns a method for preparing native collagen, comprising pretreatment of the collagen in a mixer with double transverse cutters equipped with a system controlling agitating and shearing velocity and a thermostat, and a subsequent step of sterilising the collagen in liquid medium. The invention also concerns a sterile collagen, in particular a collagen mostly of type I, in native state and in particular pharmaceutical and/or parapharmaceutical and /or medico-surgical and/or ophthalmologic an/or cosmetic compositions and applications thereof.
IL13856299A 1998-04-10 1999-04-09 Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses IL138562A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804531A FR2777284B1 (en) 1998-04-10 1998-04-10 PROCESS FOR THE STERILIZATION OF A NATIVE COLLAGEN IN A LIQUID MEDIUM, A STERILE NATIVE COLLAGEN OBTAINED, COMPOSITIONS CONTAINING THE SAME AND APPLICATIONS
PCT/FR1999/000814 WO1999052946A1 (en) 1998-04-10 1999-04-09 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses

Publications (1)

Publication Number Publication Date
IL138562A0 true IL138562A0 (en) 2001-10-31

Family

ID=9525129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13856299A IL138562A0 (en) 1998-04-10 1999-04-09 Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses

Country Status (20)

Country Link
EP (1) EP1068240B1 (en)
JP (1) JP2002511489A (en)
KR (1) KR20010042539A (en)
CN (1) CN1304416A (en)
AT (1) ATE229982T1 (en)
AU (1) AU3151499A (en)
BR (1) BR9909566A (en)
CA (1) CA2327882A1 (en)
DE (1) DE69904578T2 (en)
EE (1) EE200000592A (en)
FR (1) FR2777284B1 (en)
HU (1) HUP0102575A2 (en)
ID (1) ID26038A (en)
IL (1) IL138562A0 (en)
NO (1) NO20005079L (en)
PL (1) PL343523A1 (en)
RU (1) RU2188206C2 (en)
WO (1) WO1999052946A1 (en)
YU (1) YU61100A (en)
ZA (1) ZA200005497B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
AT411326B (en) * 2000-06-20 2003-12-29 Biering Wolfgang HEMOSTATIC COLLAGEN PELLETS
JP4705359B2 (en) * 2004-10-20 2011-06-22 新田ゼラチン株式会社 Cosmetic composition comprising avian collagen
DE102005017845A1 (en) 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptic collagen preparations, their use and methods of preparation
CN101332316B (en) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 Biotype nose bridge implantation body
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
KR101629517B1 (en) 2007-06-01 2016-06-13 교와 핫꼬 바이오 가부시키가이샤 Oral composition
RS56367B1 (en) 2011-05-24 2017-12-29 Takeda As Rolled collagen carrier
WO2013174874A1 (en) * 2012-05-24 2013-11-28 Takeda Nycomed As Apparatus and process for providing a coiled collagen carrier
US10485715B2 (en) 2012-05-24 2019-11-26 Takeda As Packaging for form-stable coiled collagen carrier
CN102846536B (en) * 2012-09-26 2014-03-26 关节动力安达（天津）生物科技有限公司 Essence containing I type collagen
RU2597085C2 (en) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Implanted matrix material for regenerative medicine and method of its production (versions)
EP3786175A4 (en) * 2018-04-27 2022-03-23 Toppan Printing Co., Ltd. Extracellular-matrix-containing composition, temporary scaffold for three-dimensional tissue formation, three-dimensional tissue formation agent, and method for recovering cells from three-dimensional tissue
RU2715715C1 (en) * 2019-03-06 2020-03-03 Общество с ограниченной ответственностью фирмы "Имтек" Sterile transparent concentrated solution of biocompatible collagen, method for production and use thereof
CN110354246A (en) * 2019-07-22 2019-10-22 中肽生物科技(大连)有限公司 A kind of preparation method of the eye-candy liquid of nanoscale small molecule complex peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2462222A1 (en) * 1974-02-02 1976-05-06 Trommsdorff Fa H Soluble human collagen free of non-helical peptides - prepd by treating purified collagen with ficin or pepsin, used to accelerate wound or burn healing etc.
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
DE3522626A1 (en) * 1985-06-25 1987-01-08 Merz & Co Gmbh & Co SOLUBLE COLLAGEN SPONGE
FR2586703B1 (en) * 1985-09-02 1989-12-01 Merieux Inst PROCESS FOR EXTRACTING PLACENTAL COLLAGENS, COLLAGENS OBTAINED IN PARTICULAR IN THE FORM OF GELS OR SOLUTIONS AND THEIR APPLICATIONS
IT1181737B (en) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Spongy matrix of natural animal collagen
FR2715309B1 (en) * 1994-01-24 1996-08-02 Imedex Adhesive composition, for surgical use, based on collagen modified by oxidative cutting and not crosslinked.
CA2146090C (en) * 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
US5670369A (en) * 1996-06-25 1997-09-23 Ranpak Corporation Method for the production of soluble collagen

Also Published As

Publication number Publication date
FR2777284A1 (en) 1999-10-15
FR2777284B1 (en) 2000-05-26
PL343523A1 (en) 2001-08-27
ATE229982T1 (en) 2003-01-15
HUP0102575A2 (en) 2001-11-28
EP1068240A1 (en) 2001-01-17
JP2002511489A (en) 2002-04-16
KR20010042539A (en) 2001-05-25
NO20005079L (en) 2000-12-08
EP1068240B1 (en) 2002-12-18
YU61100A (en) 2003-10-31
RU2188206C2 (en) 2002-08-27
NO20005079D0 (en) 2000-10-09
ID26038A (en) 2000-11-16
BR9909566A (en) 2000-12-26
EE200000592A (en) 2002-04-15
AU3151499A (en) 1999-11-01
DE69904578D1 (en) 2003-01-30
ZA200005497B (en) 2001-04-24
DE69904578T2 (en) 2003-11-20
CA2327882A1 (en) 1999-10-21
WO1999052946A1 (en) 1999-10-21
CN1304416A (en) 2001-07-18

Similar Documents

Publication Publication Date Title
IL138562A0 (en) Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses
AU2309195A (en) Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels
CA2146938A1 (en) Method of Controlling Structure Stability of Collagen Fibers Produced from Solutions or Dispersions Treated with Sodium Hydroxide for Infectious Agent Deactivation
CA2247860A1 (en) Method for treating liquid materials
CA2148583A1 (en) Viscoelastic Surfactant Based Foam Fluids
WO2003082356A3 (en) Fragrance containing emulsions
DE69919154D1 (en) HYDROCOLLOID COMPOSITION FOR USE AS GELLING AGENT, THICKENER AND STABILIZER
BR9707888A (en) Preservation and / or freezing medium for biological material, composition and storage process for biological material
WO1999049881A3 (en) Application of hsp70 proteins
AU2003285327A1 (en) Cosmetic dressings containing a waxy component, a film-forming agent and a gel-forming substance
BR9913045A (en) Process, system and container for preparing a fluid to be applied to the skin, and a razor
MX9706981A (en) Conforming shoe construction and gel compositions therefor.
AU2623895A (en) Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
DE60000050T2 (en) Cosmetic composition containing at least a powdery phase, a humectant and a galactomannan derivative and their uses
BR9810242A (en) Compositions useful as fibrin sealant
ES2073700T3 (en) COMPOSITION CONTAINING A POLYSACCHARIDE OBTAINED BY MICROBIAL FERMENTATION.
TW377281B (en) Conforming shoe construction and gel compositions therefor
BR0008386A (en) Device for applying a fluid or gel product for shaving
Johnston High pressure-A new dimension to food processing
DE69426765T2 (en) Composition for viscosity control of liquid nutrients
BR0014058A (en) Solid product, composition, aqueous solution of 4,4-dimethyl-5α-cholesta-8,14,24-triene-3 (beta) -ol, and device having a concavity
CA2297748A1 (en) Fatty emulsions containing reducing sugar and method for sterilizing the same
ATE312906T1 (en) METHOD FOR PRODUCING INSTANT AGAR MEDIUM
Yamamoto et al. Inhibitory Effect of Lead on the Release of Tissue Plasminogen Activator from Human Vascular Endothelial Cells in Culture (Proceedings of the 18th Symposium on Toxicology, and Environmental Health)
DE59906433D1 (en) Kontrasmittel auf basis polyoxyethylen-660-12-hydroxystearat und anionische phospholipide